tiprankstipranks
Medlab Clinical (AU:MDC)
ASX:MDC

Medlab Clinical (MDC) Financial Statements

0 Followers

Medlab Clinical Financial Overview

Medlab Clinical's market cap is currently ―. The company's EPS TTM is AU$-1.726; its P/E ratio is -3.82; Medlab Clinical is scheduled to report earnings on August 30, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 5.19MAU$ 13.43MAU$ 9.06MAU$ 11.44MAU$ 20.33M
Total AssetsAU$ 11.37MAU$ 20.65MAU$ 17.79MAU$ 20.20MAU$ 24.33M
Total DebtAU$ 1.12MAU$ 1.70MAU$ 2.33MAU$ 1.03MAU$ 499.70K
Net DebtAU$ -4.07MAU$ -11.74MAU$ -6.73MAU$ -10.41MAU$ -19.83M
Total LiabilitiesAU$ 3.62MAU$ 5.74MAU$ 6.53MAU$ 5.21MAU$ 2.47M
Stockholders EquityAU$ 8.08MAU$ 15.14MAU$ 11.40MAU$ 15.05MAU$ 22.88M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Medlab Clinical Earnings and Revenue History

Medlab Clinical Debt to Assets

Medlab Clinical Cash Flow

Medlab Clinical Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis